{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:34:10Z","timestamp":1794864850997,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Funding for high-efficiency post-doctoral researchers under the Second Century Fund (C2F), Chulalongkorn University"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P20GM125503"],"award-info":[{"award-number":["P20GM125503"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the NSRF via the Program Management Unit for Human Resources & Institutional Development, Research and Innovation","award":["PMU-B-B36G660004"],"award-info":[{"award-number":["PMU-B-B36G660004"]}]},{"name":"Thailand Science research and Innovation Fund Chulalongkorn University","award":["HEAF67300060"],"award-info":[{"award-number":["HEAF67300060"]}]},{"name":"Fundamental Fund 2024","award":["FF67"],"award-info":[{"award-number":["FF67"]}]},{"name":"Ratchadapiseksompotch Fund, Faculty of Medicine Chulalongkorn University","award":["RA65\/039"],"award-info":[{"award-number":["RA65\/039"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"DOI":"10.1186\/s13099-025-00782-5","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:05:50Z","timestamp":1765886750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Gut microbiota and host transcriptome interactions reveal diagnostic biomarkers in MASLD-associated hepatocellular carcinoma"],"prefix":"10.1186","volume":"17","author":[{"given":"Thananya","family":"Jinato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakkrit","family":"Khamjerm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satjapot","family":"Manprasong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nutta","family":"Iadsee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pisit","family":"Tangkijvanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Intawat","family":"Nookaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natthaya","family":"Chuaypen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"issue":"5","key":"782_CR1","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797\u2013835.","journal-title":"Hepatology"},{"issue":"1","key":"782_CR2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358\u201380.","journal-title":"Hepatology"},{"issue":"9","key":"782_CR3","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1185\/03007995.2010.506375","volume":"26","author":"A Sanyal","year":"2010","unstructured":"Sanyal A, Poklepovic A, Moyneur E, Barghout V. Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin. 2010;26(9):2183\u201391.","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"782_CR4","doi-asserted-by":"publisher","first-page":"101160","DOI":"10.1016\/j.jhepr.2024.101160","volume":"6","author":"C Vitellius","year":"2024","unstructured":"Vitellius C, Desjonqueres E, Lequoy M, Amaddeo G, Fouchard I, N\u2019Kontchou G, et al. MASLD-related HCC: multicenter study comparing patients with and without cirrhosis. JHEP Rep. 2024;6(10):101160.","journal-title":"JHEP Rep"},{"key":"782_CR5","doi-asserted-by":"publisher","unstructured":"Phoolchund AG, Khakoo SI. MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges. Cancers. 2024 Jan 6;16(2):259. https:\/\/doi.org\/10.3390\/cancers16020259.","DOI":"10.3390\/cancers16020259"},{"issue":"4","key":"782_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","volume":"11","author":"M Omata","year":"2017","unstructured":"Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317\u201370.","journal-title":"Hepatol Int"},{"issue":"1","key":"782_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. Electronic address eee, European association for the study of the L. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182\u2013236.","journal-title":"J Hepatol"},{"issue":"10290","key":"782_CR8","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"issue":"5","key":"782_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/hepr.14170","volume":"55","author":"T Cho","year":"2025","unstructured":"Cho T, Fukunaga S, Ohzono D, Tanaka H, Minami S, Nakane T, et al. Metabolic dysfunction-associated steatotic liver disease is a risk factor for gallstones: A multicenter cohort study. Hepatol Res. 2025;55(5):663\u201374.","journal-title":"Hepatol Res"},{"issue":"6","key":"782_CR10","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/hepr.14010","volume":"54","author":"T Nakane","year":"2024","unstructured":"Nakane T, Fukunaga S, Nakano D, Tsutsumi T, Tanaka H, Chou T, et al. Impact of metabolic dysfunction-associated fatty liver disease on the incidence of Helicobacter pylori-negative gastric cancer. Hepatol Res. 2024;54(6):540\u201350.","journal-title":"Hepatol Res"},{"issue":"11","key":"782_CR11","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","volume":"21","author":"CL Hsu","year":"2023","unstructured":"Hsu CL, Schnabl B. The gut-liver axis and gut microbiota in health and liver disease. Nat Rev Microbiol. 2023;21(11):719\u201333.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"782_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/gutjnl-2024-332398","volume":"74","author":"S Ha","year":"2024","unstructured":"Ha S, Wong VW, Zhang X, Yu J. Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma. Gut. 2024;74(1):141\u201352.","journal-title":"Gut"},{"issue":"1","key":"782_CR13","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.1038\/s41467-020-18754-5","volume":"11","author":"G Lee","year":"2020","unstructured":"Lee G, You HJ, Bajaj JS, Joo SK, Yu J, Park S, et al. Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD. Nat Commun. 2020;11(1):4982.","journal-title":"Nat Commun"},{"issue":"5","key":"782_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.10.015","volume":"32","author":"TG Oh","year":"2020","unstructured":"Oh TG, Kim SM, Caussy C, Fu T, Guo J, Bassirian S, et al. A universal gut-microbiome-derived signature predicts cirrhosis. Cell Metab. 2020;32(5):901.","journal-title":"Cell Metab"},{"key":"782_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.phrs.2019.01.029","volume":"141","author":"Y Ding","year":"2019","unstructured":"Ding Y, Yanagi K, Cheng C, Alaniz RC, Lee K, Jayaraman A. Interactions between gut microbiota and non-alcoholic liver disease: the role of microbiota-derived metabolites. Pharmacol Res. 2019;141:521\u20139.","journal-title":"Pharmacol Res"},{"issue":"1","key":"782_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13073-020-00796-5","volume":"12","author":"H Huang","year":"2020","unstructured":"Huang H, Ren Z, Gao X, Hu X, Zhou Y, Jiang J, et al. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma. Genome Med. 2020;12(1):102.","journal-title":"Genome Med"},{"issue":"1","key":"782_CR17","doi-asserted-by":"publisher","first-page":"17797","DOI":"10.1038\/s41598-021-96952-x","volume":"11","author":"Z Han","year":"2021","unstructured":"Han Z, Feng W, Hu R, Ge Q, Ma W, Zhang W, et al. RNA-seq profiling reveals PBMC RNA as a potential biomarker for hepatocellular carcinoma. Sci Rep. 2021;11(1):17797.","journal-title":"Sci Rep"},{"key":"782_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aba4448","author":"O Govaere","year":"2020","unstructured":"Govaere O, Cockell S, Tiniakos D, Queen R, Younes R, Vacca M, Alexander L, Ravaioli F, Palmer J, Petta S, Boursier J. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Science translational medicine. 2020 Dec 2;12(572):eaba4448. https:\/\/doi.org\/10.1126\/scitranslmed.aba4448.","journal-title":"Sci Transl Med"},{"issue":"1","key":"782_CR19","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1080\/21691401.2019.1613421","volume":"47","author":"L Yin","year":"2019","unstructured":"Yin L, He N, Chen C, Zhang N, Lin Y, Xia Q. Identification of novel blood-based HCC-specific diagnostic biomarkers for human hepatocellular carcinoma. Artif Cells Nanomed Biotechnol. 2019;47(1):1908\u201316.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1","key":"782_CR20","doi-asserted-by":"publisher","first-page":"11201","DOI":"10.1038\/s41598-021-90515-w","volume":"11","author":"P Kunadirek","year":"2021","unstructured":"Kunadirek P, Ariyachet C, Sriphoosanaphan S, Pinjaroen N, Sirichindakul P, Nookaew I, et al. Identification of BHLHE40 expression in peripheral blood mononuclear cells as a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma. Sci Rep. 2021;11(1):11201.","journal-title":"Sci Rep"},{"issue":"5","key":"782_CR21","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.cell.2013.08.003","volume":"154","author":"A Basu","year":"2013","unstructured":"Basu A, Bodycombe NE, Cheah JH, Price EV, Liu K, Schaefer GI, et al. An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules. Cell. 2013;154(5):1151\u201361.","journal-title":"Cell"},{"key":"782_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.962743","volume":"9","author":"V Raufaste-Cazavieille","year":"2022","unstructured":"Raufaste-Cazavieille V, Santiago R, Droit A. Multi-omics analysis: paving the path toward achieving precision medicine in cancer treatment and immuno-oncology. Front Mol Biosci. 2022;9:962743.","journal-title":"Front Mol Biosci"},{"issue":"2","key":"782_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13446","volume":"51","author":"Q Gu","year":"2021","unstructured":"Gu Q, Cen L, Lai J, Zhang Z, Pan J, Zhao F, et al. A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease. Eur J Clin Invest. 2021;51(2):e13446.","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"782_CR24","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cgh.2018.05.059","volume":"17","author":"C Hsu","year":"2019","unstructured":"Hsu C, Caussy C, Imajo K, Chen J, Singh S, Kaulback K, et al. Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: A systematic review and pooled analysis of individual participants. Clin Gastroenterol Hepatol. 2019;17(4):630\u2013e78.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"782_CR25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00284-022-02956-9","volume":"79","author":"S Katiraei","year":"2022","unstructured":"Katiraei S, Anvar Y, Hoving L, Berb\u00e9e JFP, van Harmelen V, van Willems K. Evaluation of full-length versus V4-region 16S rRNA sequencing for phylogenetic analysis of mouse intestinal microbiota after a dietary intervention. Curr Microbiol. 2022;79(9):276.","journal-title":"Curr Microbiol"},{"issue":"19","key":"782_CR26","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels P, Magnusson M, Lundin S, K\u00e4ller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32(19):3047\u20138.","journal-title":"Bioinformatics"},{"issue":"8","key":"782_CR27","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852\u20137.","journal-title":"Nat Biotechnol"},{"issue":"D1","key":"782_CR28","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2012","unstructured":"Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2012;41(D1):D590\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"782_CR29","doi-asserted-by":"publisher","first-page":"W180","DOI":"10.1093\/nar\/gkx295","volume":"45","author":"A Dhariwal","year":"2017","unstructured":"Dhariwal A, Chong J, Habib S, King IL, Agellon LB, Xia J. MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Res. 2017;45(W1):W180-8.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"782_CR30","first-page":"32","volume":"26","author":"MJ Anderson","year":"2001","unstructured":"Anderson MJ. A new method for non-parametric multivariate analysis of variance. Austral Ecol. 2001;26(1):32\u201346.","journal-title":"Austral Ecol"},{"issue":"9","key":"782_CR31","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nbt.2676","volume":"31","author":"MG Langille","year":"2013","unstructured":"Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31(9):814\u201321.","journal-title":"Nat Biotechnol"},{"issue":"21","key":"782_CR32","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1093\/bioinformatics\/btu494","volume":"30","author":"DH Parks","year":"2014","unstructured":"Parks DH, Tyson GW, Hugenholtz P, Beiko RG. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics. 2014;30(21):3123\u20134.","journal-title":"Bioinformatics"},{"issue":"3","key":"782_CR33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels PA, Peltzer A, Fillinger S, Patel H, Alneberg J, Wilm A, et al. The nf-core framework for community-curated bioinformatics pipelines. Nat Biotechnol. 2020;38(3):276\u20138.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"782_CR34","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41588-020-00763-1","volume":"53","author":"A Kurilshikov","year":"2021","unstructured":"Kurilshikov A, Medina-Gomez C, Bacigalupe R, Radjabzadeh D, Wang J, Demirkan A, et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet. 2021;53(2):156\u201365.","journal-title":"Nat Genet"},{"issue":"10","key":"782_CR35","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184(10):2537\u201364.","journal-title":"Cell"},{"issue":"1","key":"782_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7(1):135.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"782_CR37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","volume":"17","author":"J Aron-Wisnewsky","year":"2020","unstructured":"Aron-Wisnewsky J, Vigliotti C, Witjes J, Le P, Holleboom AG, Verheij J, et al. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat Rev Gastroenterol Hepatol. 2020;17(5):279\u201397.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"782_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","volume":"12","author":"J Behary","year":"2021","unstructured":"Behary J, Amorim N, Jiang XT, Raposo A, Gong L, McGovern E, et al. Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma. Nat Commun. 2021;12(1):187.","journal-title":"Nat Commun"},{"issue":"7785","key":"782_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","volume":"576","author":"S Hang","year":"2019","unstructured":"Hang S, Paik D, Yao L, Kim E, Trinath J, Lu J, et al. Bile acid metabolites control T(H)17 and T(reg) cell differentiation. Nature. 2019;576(7785):143\u20138.","journal-title":"Nature"},{"issue":"1","key":"782_CR40","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41420-025-02413-z","volume":"11","author":"Y Wang","year":"2025","unstructured":"Wang Y, Li Y, Lin Y, Cao C, Chen D, Huang X, et al. Roles of the gut microbiota in hepatocellular carcinoma: from the gut dysbiosis to the intratumoral microbiota. Cell Death Discov. 2025;11(1):140.","journal-title":"Cell Death Discov"},{"issue":"1","key":"782_CR41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/hep.30036","volume":"69","author":"FR Ponziani","year":"2019","unstructured":"Ponziani FR, Bhoori S, Castelli C, Putignani L, Rivoltini L, Del Chierico F, et al. Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease. Hepatology. 2019;69(1):107\u201320.","journal-title":"Hepatology"},{"issue":"1","key":"782_CR42","doi-asserted-by":"publisher","first-page":"10589","DOI":"10.1038\/s41598-021-89963-1","volume":"11","author":"S Komiyama","year":"2021","unstructured":"Komiyama S, Yamada T, Takemura N, Kokudo N, Hase K, Kawamura YI. Profiling of tumour-associated microbiota in human hepatocellular carcinoma. Sci Rep. 2021;11(1):10589.","journal-title":"Sci Rep"},{"issue":"12","key":"782_CR43","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1128\/CVI.00310-09","volume":"16","author":"G Matera","year":"2009","unstructured":"Matera G, Muto V, Vinci M, Zicca E, Abdollahi-Roodsaz S, van de Veerdonk FL, et al. Receptor recognition of and immune intracellular pathways for Veillonella parvula lipopolysaccharide. Clin Vaccine Immunol. 2009;16(12):1804\u20139.","journal-title":"Clin Vaccine Immunol"},{"issue":"6365","key":"782_CR44","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1126\/science.aam9305","volume":"358","author":"JB Spinelli","year":"2017","unstructured":"Spinelli JB, Yoon H, Ringel AE, Jeanfavre S, Clish CB, Haigis MC. Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass. Science. 2017;358(6365):941\u20136.","journal-title":"Science"},{"issue":"4","key":"782_CR45","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jhep.2018.06.023","volume":"69","author":"F De Chiara","year":"2018","unstructured":"De Chiara F, Heeboll S, Marrone G, Montoliu C, Hamilton-Dutoit S, Ferrandez A, et al. Urea cycle dysregulation in non-alcoholic fatty liver disease. J Hepatol. 2018;69(4):905\u201315.","journal-title":"J Hepatol"},{"issue":"5","key":"782_CR46","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/apt.12618","volume":"39","author":"C Nichita","year":"2014","unstructured":"Nichita C, Ciarloni L, Monnier-Benoit S, Hosseinian S, Dorta G, Ruegg C. A novel gene expression signature in peripheral blood mononuclear cells for early detection of colorectal cancer. Aliment Pharmacol Ther. 2014;39(5):507\u201317.","journal-title":"Aliment Pharmacol Ther"},{"key":"782_CR47","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev.cellbio.19.050103.103356","volume":"19","author":"M Krause","year":"2003","unstructured":"Krause M, Dent EW, Bear JE, Loureiro JJ, Gertler FB. Ena\/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol. 2003;19:541\u201364.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"5","key":"782_CR48","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1158\/1078-0432.CCR-05-2027","volume":"12","author":"F Di Modugno","year":"2006","unstructured":"Di Modugno F, Mottolese M, Di Benedetto A, Conidi A, Novelli F, Perracchio L, et al. The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive\/hormonal receptor-negative tumors. Clin Cancer Res. 2006;12(5):1470\u20138.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"782_CR49","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/s41419-018-1031-x","volume":"9","author":"D Chen","year":"2018","unstructured":"Chen D, Xu L, Li X, Chu Y, Jiang M, Xu B, et al. Enah overexpression is correlated with poor survival and aggressive phenotype in gastric cancer. Cell Death Dis. 2018;9(10):998.","journal-title":"Cell Death Dis"},{"issue":"9","key":"782_CR50","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/s41419-018-0877-2","volume":"9","author":"T Li","year":"2018","unstructured":"Li T, Huang H, Shi G, Zhao L, Li T, Zhang Z, et al. TGF-beta1-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition. Cell Death Dis. 2018;9(9):849.","journal-title":"Cell Death Dis"},{"issue":"8","key":"782_CR51","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2217\/fon.12.79","volume":"8","author":"KB Chapman","year":"2012","unstructured":"Chapman KB, Prendes MJ, Sternberg H, Kidd JL, Funk WD, Wagner J, West MD. COL10A1 expression is elevated in diverse solid tumor types and is associated with tumor vasculature. Future Oncol. 2012;8(8):1031\u201340.","journal-title":"Future Oncol"},{"key":"782_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00357","volume":"8","author":"I Fabregat","year":"2018","unstructured":"Fabregat I, Caballero-Diaz D. Transforming growth factor-beta-induced cell plasticity in liver fibrosis and hepatocarcinogenesis. Front Oncol. 2018;8:357.","journal-title":"Front Oncol"},{"key":"782_CR53","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.2147\/OTT.S160196","volume":"11","author":"H Huang","year":"2018","unstructured":"Huang H, Li T, Ye G, Zhao L, Zhang Z, Mo D, et al. High expression of COL10A1 is associated with poor prognosis in colorectal cancer. Onco Targets Ther. 2018;11:1571\u201381.","journal-title":"Onco Targets Ther"},{"issue":"8","key":"782_CR54","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1111\/jgh.17015","volume":"40","author":"L Ghani","year":"2025","unstructured":"Ghani L, Aboona MB, Faulkner CS, Rangan P, Rubin MN, Han MAT, et al. Increased mortality among lean versus non-lean adults with MASLD: a multicenter study. J Gastroenterol Hepatol. 2025;40(8):1919\u201325.","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00782-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-025-00782-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00782-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T16:01:39Z","timestamp":1766419299000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13099-025-00782-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["782"],"URL":"https:\/\/doi.org\/10.1186\/s13099-025-00782-5","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research followed the principles outlined in the Declaration of Helsinki and complied with the Rules of Good Clinical Practice. Ethics approval was obtained from the Faculty of Medicine, Chulalongkorn University Institutional Review Board (IRB Nos. 049\/63, 957\/64, and 981\/64). Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}